168 related articles for article (PubMed ID: 28077107)
1. Recurrent pneumonia among Japanese adults: disease burden and risk factors.
Ishifuji T; Sando E; Kaneko N; Suzuki M; Kilgore PE; Ariyoshi K; Morimoto K; Hosokawa N; Yaegashi M; Aoshima M;
BMC Pulm Med; 2017 Jan; 17(1):12. PubMed ID: 28077107
[TBL] [Abstract][Full Text] [Related]
2. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
[TBL] [Abstract][Full Text] [Related]
3. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.
Lin SH; Ji BC; Shih YM; Chen CH; Chan PC; Chang YJ; Lin YC; Lin CH
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1638-44. PubMed ID: 24200282
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study.
Eurich DT; Lee C; Marrie TJ; Majumdar SR
Clin Infect Dis; 2013 Oct; 57(8):1138-44. PubMed ID: 23872948
[TBL] [Abstract][Full Text] [Related]
6. Rates and risk factors for recurrent pneumonia in patients hospitalized with community-acquired pneumonia: population-based prospective cohort study with 5 years of follow-up.
Dang TT; Eurich DT; Weir DL; Marrie TJ; Majumdar SR
Clin Infect Dis; 2014 Jul; 59(1):74-80. PubMed ID: 24729503
[TBL] [Abstract][Full Text] [Related]
7. The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study.
Morimoto K; Suzuki M; Ishifuji T; Yaegashi M; Asoh N; Hamashige N; Abe M; Aoshima M; Ariyoshi K;
PLoS One; 2015; 10(3):e0122247. PubMed ID: 25822890
[TBL] [Abstract][Full Text] [Related]
8. Aetiology of, and risk factors for, recurrent community-acquired pneumonia.
Garcia-Vidal C; Carratalà J; Fernández-Sabé N; Dorca J; Verdaguer R; Manresa F; Gudiol F
Clin Microbiol Infect; 2009 Nov; 15(11):1033-8. PubMed ID: 19673961
[TBL] [Abstract][Full Text] [Related]
9. Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.
Dang TT; Majumdar SR; Marrie TJ; Eurich DT
Drugs Aging; 2015 Jan; 32(1):13-9. PubMed ID: 25491559
[TBL] [Abstract][Full Text] [Related]
10. Associations among chronic obstructive pulmonary disease with asthma, pneumonia, and corticosteroid use in the general population.
Yeh JJ; Lin CL; Kao CH
PLoS One; 2020; 15(2):e0229484. PubMed ID: 32092112
[TBL] [Abstract][Full Text] [Related]
11. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
[TBL] [Abstract][Full Text] [Related]
12. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.
Wu MF; Jian ZH; Huang JY; Jan CF; Nfor ON; Jhang KM; Ku WY; Ho CC; Lung CC; Pan HH; Wu MC; Liaw YP
BMC Cancer; 2016 Oct; 16(1):778. PubMed ID: 27724847
[TBL] [Abstract][Full Text] [Related]
13. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD.
Lai CC; Wang YH; Wang CY; Wang HC; Yu CJ; Chen L
Int J Chron Obstruct Pulmon Dis; 2018; 13():867-874. PubMed ID: 29563786
[TBL] [Abstract][Full Text] [Related]
15. Roles of sedative-hypnotics in patients with recurrent major depressive disorder: a nationwide population-based 14-year follow-up study in Taiwan.
Chung KH; Lee TY; Chung MH
Psychopharmacology (Berl); 2021 Jun; 238(6):1553-1561. PubMed ID: 33630108
[TBL] [Abstract][Full Text] [Related]
16. Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes.
Bordon J; Slomka M; Gupta R; Furmanek S; Cavallazzi R; Sethi S; Niederman M; Ramirez JA;
Clin Microbiol Infect; 2020 Feb; 26(2):220-226. PubMed ID: 31254714
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of pneumonia in middle-aged and elderly adults after hospital-treated pneumonia: aetiology and predisposing conditions.
Hedlund J; Kalin M; Ortqvist A
Scand J Infect Dis; 1997; 29(4):387-92. PubMed ID: 9360255
[TBL] [Abstract][Full Text] [Related]
18. Risk Factor Evaluation for Methicillin-Resistant
Lewis PO
Ann Pharmacother; 2021 Jan; 55(1):36-43. PubMed ID: 32545992
[TBL] [Abstract][Full Text] [Related]
19. Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis.
Arancibia F; Bauer TT; Ewig S; Mensa J; Gonzalez J; Niederman MS; Torres A
Arch Intern Med; 2002 Sep; 162(16):1849-58. PubMed ID: 12196083
[TBL] [Abstract][Full Text] [Related]
20. Specific pathogens as predictors of poor long-term prognosis after hospital discharge for community-acquired pneumonia.
Akiyama Y; Ishiguro T; Uozumi R; Nishida T; Kobayashi Y; Takayanagi N
Respir Med; 2021 Jan; 176():106279. PubMed ID: 33302145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
